Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamar Nijsten

Showing results (31-40 of 219) with videos related to

Pageof 22
Sort By:
Acta Dermato-Venereologica|May 20, 2006
Dimensionality of the dermatology life quality index (DLQI): a commentaryTamar Nijsten, David M Meads, Stephen P McKenna
Archives of Dermatology|March 17, 2004
Lymphomatoid papulosis in children: a retrospective cohort study of 35 casesTamar Nijsten, Clara Curiel-Lewandrowski, Marshall E Kadin
Journal of Cutaneous Pathology|April 7, 2005
Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursorsTamar Nijsten, Elke Geluyckens, Cecile Colpaert, et al.
The Journal of Investigative Dermatology|October 9, 2009
Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohortMarlies Wakkee, Ron M C Herings, Tamar Nijsten
Archives of Dermatology|July 12, 2012
Chemoprevention for keratinocytic (pre)cancers: balancing the risks and benefitsLoes M Hollestein, Els R Koomen, Tamar Nijsten
JAMA Dermatology|April 14, 2016
Competing Risk of Death in Kaplan-Meier Curves When Analyzing Subsequent Keratinocyte CancerJoris A C Verkouteren, Tamar Nijsten, Loes M Hollestein
Dermatology (Basel, Switzerland)|October 4, 2007
The reduced Impact of Psoriasis Questionnaire has good psychometric properties in Italian patientsTamar Nijsten, Francesca Sampogna, Robert S Stern, et al.
Archives of Dermatology|September 19, 2007
Clinical severity of psoriasis in last 20 years of PUVA studyTamar Nijsten, Caspar W N Looman, Robert S Stern
Journal of Drugs in Dermatology : JDD|March 11, 2010
Population education in preventing skin cancer: from childhood to adulthoodEllen R M de Haas, Tamar Nijsten, Esther de Vries
Archives of Dermatology|September 23, 2009
The misperception that clinical trial data reflect long-term drug safety: lessons learned from Efalizumab's withdrawalTamar Nijsten, Phyllis I Spuls, Luigi Naldi, et al.
Pageof 22

Showing results (31-40 of 219) with videos related to

Sort By:
Pageof 22
Acta Dermato-Venereologica|May 20, 2006
Dimensionality of the dermatology life quality index (DLQI): a commentaryTamar Nijsten, David M Meads, Stephen P McKenna
Archives of Dermatology|March 17, 2004
Lymphomatoid papulosis in children: a retrospective cohort study of 35 casesTamar Nijsten, Clara Curiel-Lewandrowski, Marshall E Kadin
Journal of Cutaneous Pathology|April 7, 2005
Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursorsTamar Nijsten, Elke Geluyckens, Cecile Colpaert, et al.
The Journal of Investigative Dermatology|October 9, 2009
Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohortMarlies Wakkee, Ron M C Herings, Tamar Nijsten
Archives of Dermatology|July 12, 2012
Chemoprevention for keratinocytic (pre)cancers: balancing the risks and benefitsLoes M Hollestein, Els R Koomen, Tamar Nijsten
JAMA Dermatology|April 14, 2016
Competing Risk of Death in Kaplan-Meier Curves When Analyzing Subsequent Keratinocyte CancerJoris A C Verkouteren, Tamar Nijsten, Loes M Hollestein
Dermatology (Basel, Switzerland)|October 4, 2007
The reduced Impact of Psoriasis Questionnaire has good psychometric properties in Italian patientsTamar Nijsten, Francesca Sampogna, Robert S Stern, et al.
Archives of Dermatology|September 19, 2007
Clinical severity of psoriasis in last 20 years of PUVA studyTamar Nijsten, Caspar W N Looman, Robert S Stern
Journal of Drugs in Dermatology : JDD|March 11, 2010
Population education in preventing skin cancer: from childhood to adulthoodEllen R M de Haas, Tamar Nijsten, Esther de Vries
Archives of Dermatology|September 23, 2009
The misperception that clinical trial data reflect long-term drug safety: lessons learned from Efalizumab's withdrawalTamar Nijsten, Phyllis I Spuls, Luigi Naldi, et al.
Pageof 22